Download PDF
Exp Clin Endocrinol Diabetes 2020; 128(01): 43-51
DOI: 10.1055/a-0859-7168
Article
© Georg Thieme Verlag KG Stuttgart · New York

Elevated Circulating Levels of Motilin are Associated with Diabetes in Individuals after Acute Pancreatitis

Fuchsia D. Gold-Smith
1   School of Medicine, University of Auckland, Auckland, New Zealand
,
Ruma G. Singh
1   School of Medicine, University of Auckland, Auckland, New Zealand
,
Maxim S. Petrov
1   School of Medicine, University of Auckland, Auckland, New Zealand
› Author Affiliations Acknowledgement: This study was part of the Clinical and epidemiological inveStigations in Metabolism, nutrition, and pancreatic diseaseS (COSMOS) programme. COSMOS is supported in part by the Auckland Medical Research Foundation (grant 1116021 to Associate Professor Max Petrov), which played no role in the study design; collection, analysis, or interpretation of data; or writing of the manuscript.
Further Information

Publication History

received 21 November 2018
revised 14 January 2019

accepted 18 February 2019

Publication Date:
14 March 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Aim The study aimed to investigate the associations between glycaemic control after acute pancreatitis and gastrointestinal motility, using plasma motilin concentration and gastroparesis cardinal symptom index score as proxies.

Methods This cross-sectional study recruited a total of 93 individuals after acute pancreatitis. Gastroparesis cardinal index scores, demographic and anthropometric factors, as well as pancreatitis-related factors were analysed. Fasting venous blood was collected to measure motilin, glycated haemoglobin, and fasting blood glucose. Linear regression analyses were conducted to investigate the associations between glycaemic control and gastrointestinal motility in unadjusted and adjusted models.

Results Motilin was significantly higher in individuals with diabetes across all adjusted models, with the highest ß-coefficient (95% confidence interval) of 588.89 (138.50, 1039.28); P=0.010. Fasting blood glucose was significantly associated with motilin across all models, with the highest ß-coefficient (95% confidence interval) of 156.30 (55.49, 257.10); P=0.002. Glycated haemoglobin was significantly associated with motilin in one adjusted model with ß-coefficient (95% confidence interval) of 18.78 (1.53, 36.02); P=0.033. Gastroparesis cardinal symptom index was not significantly associated with any measure of glycaemic control.

Conclusions Diabetes in individuals after acute pancreatitis appears to be characterised by elevated plasma motilin but not gastroparesis cardinal symptom index. The role of motilin in this setting warrants further investigations.

Key words

acute pancreatitis - diabetes mellitus - gastroparesis - gastroparesis cardinal symptom index - motilin
 

  • References

  • 1 Xiao AY, Tan ML, Wu LM. et al. Global incidence and mortality of pancreatic diseases: A systematic review, meta-analysis, and meta-regression of population-based cohort studies. Lancet Gastroenterol Hepatol 2016; 1: 45-55
    CrossrefPubMedGoogle Scholar
  • 2 Peery AF, Crockett SD, Barritt AS. et al. Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 2015; 149: 1731-1741
    CrossrefPubMedGoogle Scholar
  • 3 Chand SK, Singh RG, Pendharkar SA. et al. Iron: A strong element in the pathogenesis of chronic hyperglycaemia after acute pancreatitis. Biol Trace Elem Res. 2017: 1-9
    Google Scholar
  • 4 Gillies NA, Pendharkar SA, Singh RG. et al. Lipid metabolism in patients with chronic hyperglycemia after an episode of acute pancreatitis. Diabetes Metab Syndr 2016; 11: S233-S241
    PubMedGoogle Scholar
  • 5 Gillies NA, Pendharkar SA, Singh RG. et al. Fasting levels of insulin and amylin after acute pancreatitis are associated with pro-inflammatory cytokines. Arch Physiol Biochem 2017; 123: 238-248
    CrossrefPubMedGoogle Scholar
  • 6 Pendharkar SA, Asrani VM, Xiao AY. et al. Relationship between pancreatic hormones and glucose metabolism: a cross-sectional study in patients after acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2016; 311: G50-G58
    CrossrefPubMedGoogle Scholar
  • 7 Pendharkar SA, Drury M, Walia M. et al. Gastrin-releasing peptide and glucose metabolism following pancreatitis. Gastroenterology Res 2017; 10: 224-234
    PubMedGoogle Scholar
  • 8 Bharmal SH, Pendharkar SA, Singh RG. et al. Relationship between circulating levels of pancreatic proteolytic enzymes and pancreatic hormones. Pancreatology 2017; 17: 876-883
    CrossrefPubMedGoogle Scholar
  • 9 Das SL, Singh PP, Phillips AR. et al. Newly diagnosed diabetes mellitus after acute pancreatitis: A systematic review and meta-analysis. Gut 2014; 63: 818
    CrossrefPubMedGoogle Scholar
  • 10 Párniczky A, Kui B, Szentesi A. et al. Prospective, multicentre, nationwide clinical data from 600 cases of acute pancreatitis. PLoS One 2016; 11: e0165309
    CrossrefPubMedGoogle Scholar
  • 11 Zimmet P, Alberti KG, Magliano DJ. et al. Diabetes mellitus statistics on prevalence and mortality: facts and fallacies. Nat Rev Endocrinol 2016; 12: 616-622
    CrossrefPubMedGoogle Scholar
  • 12 WHO. Global report on diabetes. World Health Organization; 2016
    Google Scholar
  • 13 Pendharkar SA, Asrani VM, Murphy R. et al. The Role of gut-brain axis in regulating glucose metabolism after acute pancreatitis. Clin Transl Gastroenterol 2017; 8: 1-10
    PubMedGoogle Scholar
  • 14 Pendharkar SA, Singh RG, Petrov MS. Cross-talk between innate cytokines and the pancreatic polypeptide family in acute pancreatitis. Cytokine 2017; 90: 161-168
    CrossrefPubMedGoogle Scholar
  • 15 Chand SK, Singh RG, Pendharkar SA. et al. Interplay between innate immunity and iron metabolism after acute pancreatitis. Cytokine 2018; 103: 90-98
    CrossrefPubMedGoogle Scholar
  • 16 Singh RG, Pendharkar SA, Gillies NA. et al. Associations between circulating levels of adipocytokines and abdominal adiposity in patients after acute pancreatitis. Clin Exp Med 2017; 17: 477-487
    CrossrefPubMedGoogle Scholar
  • 17 Singh RG, Pendharkar SA, Plank LD. et al. Role of human lipocalin proteins in abdominal obesity after acute pancreatitis. Peptides 2017; 91: 1-7
    CrossrefPubMedGoogle Scholar
  • 18 Tack J, Rotondo A, Meulemans A. et al. Randomized clinical trial: A controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis. Neurogastroenterol Motil 2016; 28: 487-497
    CrossrefPubMedGoogle Scholar
  • 19 Pasricha PJ, Yates KP, Nguyen L. et al. Outcomes and factors associated with reduced symptoms in patients with gastroparesis. Gastroenterology 2015; 149: 1762-1774
    CrossrefPubMedGoogle Scholar
  • 20 Kofod-Andersen K, Tarnow L. Prevalence of gastroparesis-related symptoms in an unselected cohort of patients with type 1 diabetes. J Diabetes Complications 2012; 26: 89-93
    CrossrefPubMedGoogle Scholar
  • 21 Shin A, Camilleri M, Busciglio I. et al. Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying pharmacokinetics and pharmacodynamics. Diabetes Care 2013; 36: 41-48
    CrossrefPubMedGoogle Scholar
  • 22 Shin A, Camilleri M, Busciglio I. et al. The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus. Clin Gastroenterol Hepatol 2013; 11: 1453-1459
    CrossrefPubMedGoogle Scholar
  • 23 Gebel E. Diabetes 101. Gastroparesis. Feeling full. This nerve disorder can leave your stomach out of sync. Diabetes Forecast 2009; 62: 39-40
    PubMedGoogle Scholar
  • 24 Gold-Smith FD, Chand SK, Petrov MS. Post-pancreatitis diabetes mellitus: towards understanding the role of gastrointestinal motility. Minerva Gastroenterol Dietol 2018; 64: 363-375
    PubMedGoogle Scholar
  • 25 Wu LM, Sankaran SJ, Plank LD. et al. Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis. Br J Surg 2014; 101: 1644-1656
    CrossrefPubMedGoogle Scholar
  • 26 Bevan MG, Asrani VM, Pendharkar SA. et al. Nomogram for predicting oral feeding intolerance in patients with acute pancreatitis. Nutrition 2017; 36: 41-45
    CrossrefPubMedGoogle Scholar
  • 27 Wu LM, Pendharkar SA, Asrani VM. et al. Effect of intravenous fluids and analgesia on dysmotility in patients with acute pancreatitis: A prospective cohort study. Pancreas 2017; 46: 858-866
    CrossrefPubMedGoogle Scholar
  • 28 Wu LM, Premkumar R, Phillips AR. et al. Ghrelin and gastroparesis as early predictors of clinical outcomes in acute pancreatitis. Pancreatology 2016; 16: 181-188
    CrossrefPubMedGoogle Scholar
  • 29 Ma J, Pendharkar SA, O’Grady G. et al. Effect of nasogastric tube feeding vs nil per os on dysmotility in acute pancreatitis: Results of a randomized controlled trial. Nutr Clin Pract 2016; 31: 99-104
    CrossrefPubMedGoogle Scholar
  • 30 Petrov MS. The nescience and nascence of gastrointestinal motility research in acute pancreatitis. Scand J Gastroenterol 2017; 52: 615-616
    CrossrefPubMedGoogle Scholar
  • 31 Revicki DA, Camilleri M, Kuo B. et al. Evaluating symptom outcomes in gastroparesis clinical trials: Validity and responsiveness of the Gastroparesis Cardinal Symptom Index-Daily Diary (GCSI-DD). Neurogastroenterol Motil 2012; 24: 456-463
    CrossrefPubMedGoogle Scholar
  • 32 Revicki DA, Rentz AM, Dubois D. et al. Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res 2004; 13: 833-844
    CrossrefPubMedGoogle Scholar
  • 33 Cassilly DW, Wang YR, Friedenberg FK. et al. Symptoms of gastroparesis: use of the gastroparesis cardinal symptom index in symptomatic patients referred for gastric emptying scintigraphy. Digestion 2008; 78: 144-151
    CrossrefPubMedGoogle Scholar
  • 34 Revicki D, Rentz A, Dubois D. et al. Development and validation of a patient-assessed gastroparesis symptom severity measure: The Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther 2003; 18: 141-150
    CrossrefPubMedGoogle Scholar
  • 35 Revicki DA, Camilleri M, Kuo B. et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther 2009; 30: 670-680
    CrossrefPubMedGoogle Scholar
  • 36 Ohno T, Mochiki E, Kuwano H. The roles of motilin and ghrelin in gastrointestinal motility. Int J Pept 2010 2010; 1-6
    PubMedGoogle Scholar
  • 37 Poitras P. Motilin is a digestive hormone in the dog. Gastroenterology 1984; 87: 909-913
    CrossrefPubMedGoogle Scholar
  • 38 Luiking YC, Peeters TL, Stolk MF. et al. Motilin induces gall bladder emptying and antral contractions in the fasted state in humans. Gut 1998; 42: 830-835
    CrossrefPubMedGoogle Scholar
  • 39 Kamerling I, Van Haarst A, Burggraaf J. et al. Dose-related effects of motilin on proximal gastrointestinal motility. Aliment Pharmacol Ther 2002; 16: 129-135
    CrossrefPubMedGoogle Scholar
  • 40 Deloose E, Vos R, Corsetti M. et al. Endogenous motilin, but not ghrelin plasma levels fluctuate in accordance with gastric phase III activity of the migrating motor complex in man. Neurogastroenterol Motil 2015; 27: 63-71
    CrossrefPubMedGoogle Scholar
  • 41 Wang X, Gong Z, Wu K. et al. Gastrointestinal dysmotility in patients with acute pancreatitis. J Gastroenterol Hepatol 2003; 18: 57-62
    CrossrefPubMedGoogle Scholar
  • 42 Imura H, Seino Y, Mori K. et al. Plasma motilin levels in normal subjects and patients with diabetes mellitus and certain other diseases. Fasting levels and responses to food and glucose. Endocrinol Jpn 1980; 27: 151-155
    CrossrefPubMedGoogle Scholar
  • 43 Fiorucci S, Scionti L, Bosso R. et al. Effect of erythromycin on gallbladder emptying in diabetic patients with and without autonomic neuropathy and high levels of motilin. Dig Dis Sci 1992; 37: 1671-1677
    CrossrefPubMedGoogle Scholar
  • 44 Kawagishi T, Nishizawa Y, Okuno Y. et al. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gastroenterol 1993; 88: 933-938
    PubMedGoogle Scholar
  • 45 Achem-Karam SR, Funakoshi A, Vinik AI. et al. Plasma motilin concentration and interdigestive migrating motor complex in diabetic gastroparesis: effect of metoclopramide. Gastroenterology 1985; 88: 492-499
    CrossrefPubMedGoogle Scholar
  • 46 Maravi-Poma E, Zubia Olascoaga F, Petrov MS. et al. SEMICYUC 2012. Recommendations for intensive care management of acute pancreatitis. Med Intensiva 2013; 37: 163-179
    CrossrefPubMedGoogle Scholar
  • 47 Gillies NA, Pendharkar SA, Asrani VM. et al. Interleukin-6 is associated with chronic hyperglycemia and insulin resistance in patients after acute pancreatitis. Pancreatology 2016; 16: 748-755
    CrossrefPubMedGoogle Scholar
  • 48 Petrov MS. Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon. Pancreatology 2017; 17: 523-526
    CrossrefPubMedGoogle Scholar
  • 49 Eibl G, Cruz-Monserrate Z, Korc M. et al. Diabetes mellitus and obesity as risk factors for pancreatic cancer. J Acad Nutr Diet 2018; 118: 555-567
    CrossrefPubMedGoogle Scholar
  • 50 Petrov MS, Windsor JA. Conceptual framework for classifying the severity of acute pancreatitis. Clin Res Hepatol Gastroenterol 2012; 36: 341-344
    CrossrefPubMedGoogle Scholar
  • 51 Meyers LS, Gamst G, Guarino AJ. Applied multivariate research: Design and interpretation. Sage publications; 2016
    Google Scholar
  • 52 Das SL, Kennedy JI, Murphy R. et al. Relationship between the exocrine and endocrine pancreas after acute pancreatitis. World J Gastroenterol 2014; 20: 17196-17205
    CrossrefPubMedGoogle Scholar
  • 53 Dellinger EP, Forsmark CE, Layer P. et al. Determinant-based classification of acute pancreatitis severity: An international multidisciplinary consultation. Ann Surg 2012; 256: 875-880
    CrossrefPubMedGoogle Scholar
  • 54 Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 5-12
    CrossrefPubMedGoogle Scholar
  • 55 Parkman HP, Yates K, Hasler WL. et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol 2011; 9: 1056-1064
    CrossrefPubMedGoogle Scholar
  • 56 Singh RG, Nguyen NN, DeSouza SV. et al. Comprehensive analysis of body composition and insulin traits associated with intra-pancreatic fat deposition in healthy individuals and people with new-onset prediabetes/diabetes after acute pancreatitis. Diabetes Obes Metab 2019; 21: 417-423
    CrossrefPubMedGoogle Scholar
  • 57 DeSouza SV, Singh RG, Yoon HD. et al. Pancreas volume in health and disease: A systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol 2018; 12: 757-766
    CrossrefPubMedGoogle Scholar
  • 58 Pendleton H, Ekman R, Olsson R. et al. Motilin concentrations in relation to gastro intestinal dysmotility in diabetes mellitus. Eur J Intern Med 2009; 20: 654-659
    CrossrefPubMedGoogle Scholar
  • 59 Peeters TL, Muls E, Janssens J. et al. Effect of motilin on gastric emptying in patients with diabetic gastroparesis. Gastroenterology 1992; 102: 97-101
    CrossrefPubMedGoogle Scholar
  • 60 Chiu YC, Kuo MC, Rayner CK. et al. Decreased gastric motility in type II diabetic patients. Biomed Res Int 2014 2014; 1-6
    PubMedGoogle Scholar
  • 61 Brown JC, Cook MA, Dryburgh JR. Motilin, a gastric motor activity-stimulating polypeptide: final purification, amino acid composition, and C-terminal residues. Gastroenterology 1972; 62: 401-404
    CrossrefPubMedGoogle Scholar
  • 62 Miegueu P, Cianflone K, Richard D. et al. Motilin stimulates preadipocyte proliferation and differentiation and adipocyte lipid storage. Am J Physiol Endocrinol Metab 2011; 301: E758-E766
    CrossrefPubMedGoogle Scholar
  • 63 Suzuki H, Kuwano H, Mochiki E. et al. Effect of motilin on endogenous release of insulin in conscious dogs in the fed state. Dig Dis Sci 2003; 48: 2263-2270
    CrossrefPubMedGoogle Scholar
  • 64 Hanson M, Almér LO, Ekman R. et al. Motilin response to a glucose load aberrant in smokers. Scand J Gastroenterol 1987; 22: 809-812
    CrossrefPubMedGoogle Scholar
  • 65 Ransohoff DF, Feinstein AR. Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med 1978; 299: 926-930
    CrossrefPubMedGoogle Scholar
  • 66 Pendharkar SA, Singh RG, Cervantes A et al. Gut hormone responses to mixed meal test in new-onset prediabetes/diabetes after acute pancreatitis. Horm Metab Res 2018 [Epub ahead of print]
    PubMed
  • 67 Bharmal SH, Pendharkar SA, Singh RG. et al. Associations between gastrointestinal humoral factors and pancreatic proteolytic enzymes in alcohol-related versus non-alcohol-related pancreatitis. Alcohol 2019; 76: 1-10
    CrossrefPubMedGoogle Scholar
  • 68 Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol 2019; 16: 175-184
    Google Scholar
  • 69 Pendharkar SA, Singh RG, Bharmal SH et al. Pancreatic hormone responses to mixed meal test in new-onset prediabetes/diabetes after non-necrotizing acute pancreatitis. J Clin Gastroenterol 2018 [Epub ahead of print]
    PubMed
  • 70 Bharmal SH, Pendharkar SA, Singh RG et al. Associations between ketone bodies and fasting plasma glucose in individuals with post-pancreatitis prediabetes. Arch Physiol Biochem 2018 [Epub ahead of print]
    PubMed
  • 71 Singh RG, Pendharkar SA, Cervantes A. et al. Abdominal obesity and insulin resistance after an episode of acute pancreatitis. Dig Liver Dis 2018; 50: 1081-1087
    CrossrefPubMedGoogle Scholar
  • 72 Cervantes A, Singh RG, Pendharkar SA. et al. Profile of gut hormones, pancreatic hormones and pro-inflammatory cytokines in New Zealand Maori. Gastroenterol Res 2018; 11: 280-289
    CrossrefPubMedGoogle Scholar
  • 73 Pendharkar SA, Singh RG, Chand SK. et al. Pro-inflammatory cytokines after an episode of acute pancreatitis: associations with fasting gut hormone profile. Inflamm Res 2018; 67: 339-350
    CrossrefPubMedGoogle Scholar
  • 74 Collins SM, Lewis TD, Fox JE. et al. Changes in plasma motilin concentration in response to manipulation of intragastric and intraduoduenal contents in man. Can J Physiol Pharmacol 1981; 59: 188-194
    CrossrefPubMedGoogle Scholar